Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2 -Negative Advanced Breast Cancer: A Randomized Clinical Trial

1. Llombart-Cussac, A.
2. Pérez-García, J.M.
3. Bellet, M.
4. Dalenc, F.
5. Gil-Gil, M.
6. Ruíz-Borrego, M.
7. Gavilá, J.
8. Sampayo-Cordero, M.
9. Aguirre, E.
10. Schmid, P.
11. Marmé, F.
12. Di Cosimo, S.
13. Gligorov, J.
14. Schneeweiss, A.
15. Albanell, J.
16. Zamora, P.
17. Wheatley, D.
18. Martínez-De Dueñas, E.
19. Amillano, K.
20. Malfettone, A.
21. Cortés, J.